The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,274.00
Bid: 1,268.00
Ask: 1,276.00
Change: 0.00 (0.00%)
Spread: 8.00 (0.631%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,274.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Apr 2022 07:00

RNS Number : 2091H
Victrex PLC
05 April 2022
 
 

 

April 5, 2022

Victrex plc

Directorate change

Victrex appoints Ian Melling of Smith & Nephew plc as Chief Financial Officer

Ian to succeed Richard Armitage as CFO

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. The Group is pleased to announce that Ian Melling has been appointed as Chief Financial Officer (CFO) and as an Executive Director of the Board, to succeed Richard Armitage.

As previously communicated, Richard will step down as CFO and from the Board on 27th May 2022. Ian will join Victrex and the Board on 4th July 2022. The appointment follows a diverse and thorough search process. In the intervening period, Mike Ward, Finance Director, who has been with Victrex for nine years, will assume the role of interim CFO.

Career history:

Ian Melling, FCA, is a Chartered Accountant and currently Senior Vice-President, Corporate Finance and R&D for Smith & Nephew plc, the medical technology company, having served as Interim Chief Financial Officer during 2020. Ian has served in a number of senior finance roles in the UK and internationally for Smith & Nephew, including those with divisional and functional responsibility, having joined the Group in 2006. He served as Senior Vice-President Group Finance for five years until October 2021, prior to his current role.

 

His other roles have included Vice-President Finance for Spine & Biologics in the USA. Prior to joining Smith & Nephew plc, Ian was an Audit Manager for Deloitte in London. He holds a first class Masters degree in Chemistry from Oxford University.

 

Commenting on the appointment:

Dame Vivienne Cox, Chair of Victrex, said: "The Board is delighted that Ian has agreed to join Victrex. He is a commercially focused CFO, with listed company experience and a wealth of knowledge from an innovative global growth business. His background in Medical will also be beneficial for Victrex, as this is an end-market where we hold significant value and where we expect to see good growth over the years ahead. The Board would like to thank Richard for his contribution to Victrex and we look forward to welcoming Ian in due course."

 

Jakob Sigurdsson, Chief Executive of Victrex, said: "We are all looking forward to Ian joining Victrex as we continue to deliver on our Polymer & Parts strategy, with a strong and growing core business supported by our potentially game-changing mega-programmes. Our growth opportunities continue to build and Ian's experience will support us across Industrial and also in Medical, which we anticipate will become a larger part of the Group in the future."

 

There is no further information to be disclosed under Listing Rule 9.6.13

 

Notes:

1/ Ian will be appointed on a base salary of £350,000.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 1253 898121

+44 (0) 7809 595831

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEASLLESEAEFA
Date   Source Headline
30th Apr 20242:54 pmRNSTotal Voting Rights
28th Mar 20249:56 amRNSTotal Voting Rights
15th Mar 20248:30 amRNSDirectorate Change
6th Mar 20242:06 pmRNSDirector/PDMR Shareholding
29th Feb 20249:36 amRNSTotal Voting Rights
21st Feb 20248:00 amRNSBlock listing Interim Review
9th Feb 202412:16 pmRNSResult of AGM
9th Feb 20247:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202412:26 pmRNSTotal Voting Rights
25th Jan 202410:57 amRNSHolding(s) in Company
9th Jan 202412:13 pmRNSAnnual Report & Accounts
29th Dec 20239:00 amRNSTotal Voting Rights
12th Dec 202310:21 amRNSDirector/PDMR Shareholding
5th Dec 20232:42 pmRNSDirector/PDMR Shareholding
5th Dec 20232:33 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSVictrex plc - Preliminary Results 2023
1st Dec 202310:41 amRNSBlock listing Interim Review
30th Nov 202311:10 amRNSTotal Voting Rights
3rd Nov 20231:31 pmRNSHolding(s) in Company
31st Oct 20239:36 amRNSTotal Voting Rights
19th Sep 20231:59 pmRNSDirector/PDMR Shareholding
8th Sep 20239:32 amRNSHolding(s) in Company
31st Aug 20239:30 amRNSTotal Voting Rights
23rd Aug 202310:52 amRNSHolding(s) in Company
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20239:39 amRNSTotal Voting Rights
18th Jul 202311:51 amRNSDirector/PDMR Shareholding
13th Jul 20232:00 pmRNSAdditional Listing
6th Jul 20237:00 amRNSVictrex plc - Q3 Interim Management Statement
3rd Jul 20234:03 pmRNSHolding(s) in Company
30th Jun 20239:37 amRNSTotal Voting Rights
27th Jun 202310:08 amRNSDirector/PDMR Shareholding
19th Jun 20232:27 pmRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSTrading Statement
1st Jun 202312:08 pmRNSBlock listing Interim Review
31st May 20239:52 amRNSTotal Voting Rights
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding
13th Mar 202310:14 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.